Multidisciplinary management of stage IV colon cancer
作者： Y. Nancy You , Cathy Eng , Thomas Aloia
DOI: 10.1053/J.SCRS.2016.04.020
关键词:
摘要: Significant advances in systemic chemotherapy and surgical techniques have allowed a subset of patients with stage IV colorectal cancer to be suitable candidates for multimodality therapy curative intent. Care these requires multidisciplinary coordination, close monitoring disease response, individualized treatment plan. This review will discuss considerations planning sequencing symptomatic asymptomatic primary colon the setting potentially resectable liver metastases.
seminarscolonrectalsurgery.com参考文章(41)
George A. Poultsides, Phillip B. Paty, Reassessing the need for primary tumor surgery in unresectable metastatic colorectal cancer: overview and perspective. Therapeutic Advances in Medical Oncology. ,vol. 3, pp. 35- 42 ,(2011) , 10.1177/1758834010386283
Thomas A. Aloia, Giuseppe Zimmitti, Claudius Conrad, Vijaya Gottumukalla, Scott Kopetz, Jean-Nicolas Vauthey, Return to intended oncologic treatment (RIOT): a novel metric for evaluating the quality of oncosurgical therapy for malignancy. Journal of Surgical Oncology. ,vol. 110, pp. 107- 114 ,(2014) , 10.1002/JSO.23626
Chiara Cremolini, Fotios Loupakis, Carlotta Antoniotti, Cristiana Lupi, Elisa Sensi, Sara Lonardi, Silvia Mezi, Gianluca Tomasello, Monica Ronzoni, Alberto Zaniboni, Giuseppe Tonini, Chiara Carlomagno, Giacomo Allegrini, Silvana Chiara, Mauro D'Amico, Cristina Granetto, Marina Cazzaniga, Luca Boni, Gabriella Fontanini, Alfredo Falcone, FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study The Lancet Oncology. ,vol. 16, pp. 1306- 1315 ,(2015) , 10.1016/S1470-2045(15)00122-9
Christophe Tournigand, Thierry André, Emmanuel Achille, Gérard Lledo, Michel Flesh, Dominique Mery-Mignard, Emmanuel Quinaux, Corinne Couteau, Marc Buyse, Gérard Ganem, Bruno Landi, Philippe Colin, Christophe Louvet, Aimery de Gramont, FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study Journal of Clinical Oncology. ,vol. 22, pp. 229- 237 ,(2004) , 10.1200/JCO.2004.05.113
Carol-Anne Moulton, Chu-Shu Gu, Calvin H. Law, Ved R. Tandan, Richard Hart, Douglas Quan, Robert J. Fairfull Smith, Diederick W. Jalink, Mohamed Husien, Pablo E. Serrano, Aaron L. Hendler, Masoom A. Haider, Leyo Ruo, Karen Y. Gulenchyn, Terri Finch, Jim A. Julian, Mark N. Levine, Steven Gallinger, Effect of PET Before Liver Resection on Surgical Management for Colorectal Adenocarcinoma Metastases: A Randomized Clinical Trial JAMA. ,vol. 311, pp. 1863- 1869 ,(2014) , 10.1001/JAMA.2014.3740
Leonard B. Saltz, Stephen Clarke, Eduardo Díaz-Rubio, Werner Scheithauer, Arie Figer, Ralph Wong, Sheryl Koski, Mikhail Lichinitser, Tsai-Shen Yang, Fernando Rivera, Felix Couture, Florin Sirzén, Jim Cassidy, Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study Journal of Clinical Oncology. ,vol. 26, pp. 2013- 2019 ,(2008) , 10.1200/JCO.2007.14.9930
Bernard Nordlinger, Halfdan Sorbye, Bengt Glimelius, Graeme J Poston, Peter M Schlag, Philippe Rougier, Wolf O Bechstein, John N Primrose, Euan T Walpole, Meg Finch-Jones, Daniel Jaeck, Darius Mirza, Rowan W Parks, Murielle Mauer, Erik Tanis, Eric Van Cutsem, Werner Scheithauer, Thomas Gruenberger, None, Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial The Lancet Oncology. ,vol. 14, pp. 1208- 1215 ,(2013) , 10.1016/S1470-2045(13)70447-9
Yun Shin Chun, Jean-Nicolas Vauthey, Piyaporn Boonsirikamchai, Dipen M Maru, Scott Kopetz, Martin Palavecino, Steven A Curley, Eddie K Abdalla, Harmeet Kaur, Chusilp Charnsangavej, Evelyne M Loyer, Association of Computed Tomography Morphologic Criteria With Pathologic Response and Survival in Patients Treated With Bevacizumab for Colorectal Liver Metastases JAMA. ,vol. 302, pp. 2338- 2344 ,(2009) , 10.1001/JAMA.2009.1755
George A. Poultsides, Elliot L. Servais, Leonard B. Saltz, Sujata Patil, Nancy E. Kemeny, Jose G. Guillem, Martin Weiser, Larissa K.F. Temple, W. Douglas Wong, Phillip B. Paty, Outcome of Primary Tumor in Patients With Synchronous Stage IV Colorectal Cancer Receiving Combination Chemotherapy Without Surgery As Initial Treatment Journal of Clinical Oncology. ,vol. 27, pp. 3379- 3384 ,(2009) , 10.1200/JCO.2008.20.9817
Herbert Hurwitz, Louis Fehrenbacher, William Novotny, Thomas Cartwright, John Hainsworth, William Heim, Jordan Berlin, Ari Baron, Susan Griffing, Eric Holmgren, Napoleone Ferrara, Gwen Fyfe, Beth Rogers, Robert Ross, Fairooz Kabbinavar, None, BEVACIZUMAB PLUS IRINOTECAN, FLUOROURACIL, AND LEUCOVORIN FOR METASTATIC COLORECTAL CANCER The New England Journal of Medicine. ,vol. 350, pp. 2335- 2342 ,(2004) , 10.1056/NEJMOA032691